These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

418 related articles for article (PubMed ID: 22728558)

  • 1. [Contingent diagnosis of sarcoidosis by 18F-fluorodeoxyglucose-positron emission tomography (FDG-PET) after completion of chemotherapy for malignant lymphoma].
    Iino M; Iizuka C
    Rinsho Ketsueki; 2012 May; 53(5):540-2. PubMed ID: 22728558
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnostic usefulness of fluorine-18-alpha-methyltyrosine positron emission tomography in combination with 18F-fluorodeoxyglucose in sarcoidosis patients.
    Kaira K; Oriuchi N; Otani Y; Yanagitani N; Sunaga N; Hisada T; Ishizuka T; Endo K; Mori M
    Chest; 2007 Apr; 131(4):1019-27. PubMed ID: 17426205
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differentiation of sarcoidosis-lymphoma syndrome lesions: a case report on the use of two different positron emission tomography tracers.
    Yudistiro R; Arisaka Y; Tokue A; Nakajima T
    BMC Med Imaging; 2016 Jan; 16():1. PubMed ID: 26746426
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The scar sign: a useful finding on FDG PET/CT to distinguish sarcoidosis from other causes of lymphadenopathy.
    Lu SJ; Lee VK; Loo SW
    Clin Nucl Med; 2013 Mar; 38(3):205-8. PubMed ID: 23354040
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative evaluation of 18F-FDG PET and 67Ga scintigraphy in patients with sarcoidosis.
    Nishiyama Y; Yamamoto Y; Fukunaga K; Takinami H; Iwado Y; Satoh K; Ohkawa M
    J Nucl Med; 2006 Oct; 47(10):1571-6. PubMed ID: 17015889
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Sarcoidosis-lymphoma syndrome showing abnormal FDG uptake in lymph nodes and muscles upon post-chemotherapy PET/CT imaging].
    Nakano K; Ito Y; Takagi F; Uchiyama S; Yoda A; Sakamoto N; Takaba M; Adachi M; Takemura T; Nagata Y; Ono T
    Rinsho Ketsueki; 2019; 60(4):302-307. PubMed ID: 31068560
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of integrated FDG-PET/CT in sarcoidosis.
    Krüger S; Buck AK; Mottaghy FM; Pauls S; Schelzig H; Hombach V; Reske SN
    Clin Imaging; 2008; 32(4):269-73. PubMed ID: 18603181
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cervical and axillary lymph node sarcoidosis misdiagnosed as lymphoma on F-18 FDG PET-CT.
    Li YJ; Zhang Y; Gao S; Bai RJ
    Clin Nucl Med; 2007 Mar; 32(3):262-4. PubMed ID: 17314619
    [No Abstract]   [Full Text] [Related]  

  • 9. Impact of [18F]-fluorodeoxyglucose ([18F]-FDG) imaging in sarcoidosis: unsuspected neurosarcoidosis discovered by [18F]-FDG PET and early metabolic response to corticosteroid therapy.
    Aide N; Benayoun M; Kerrou K; Khalil A; Cadranel J; Talbot JN
    Br J Radiol; 2007 Mar; 80(951):e67-71. PubMed ID: 17548505
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diffuse renal (18)F-FDG uptake of a patient with fever of unknown origin revealed sarcoidosis.
    Toyonaga T; Manabe O; Gaertner FC; Nakagaki T; Nishio S; Suzuki A; Tamaki N
    Clin Nucl Med; 2014 Jul; 39(7):648-9. PubMed ID: 24873783
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Usefulness of fluorodeoxyglucose-positron emission tomography in a case of pleural sarcoidosis].
    Hattori T; Konno S; Inomata T; Nasuhara Y; Betsuyaku T; Nishimura M
    Nihon Kokyuki Gakkai Zasshi; 2009 Jul; 47(7):658-62. PubMed ID: 19637812
    [TBL] [Abstract][Full Text] [Related]  

  • 12. False-positive finding in FDG-PET in a patient with seminoma and sarcoidosis.
    Liepe K
    Acta Clin Belg; 2015 Apr; 70(2):138-40. PubMed ID: 25409626
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comparison of the features of fluorine-18 fluorodeoxyglucose-positron emission tomography (FDG-PET) between IgG4-related disease with bilateral hilar lymphadenopathy and sarcoidosis.
    Ozawa Y; Yamamoto H; Yasuo M; Komatsu M; Ushiki A; Hamano H; Uehara T; Kawakami S; Fujita A; Fujinaga Y; Oguchi K; Kawa S; Hanaoka M
    Nagoya J Med Sci; 2020 Feb; 82(1):101-111. PubMed ID: 32273638
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combined C-11 methionine and F-18 FDG PET imaging in a case of neurosarcoidosis.
    Ng D; Jacobs M; Mantil J
    Clin Nucl Med; 2006 Jul; 31(7):373-5. PubMed ID: 16785800
    [TBL] [Abstract][Full Text] [Related]  

  • 15. FDG PET for esophageal cancer complicated by sarcoidosis mimicking mediastinal and hilar lymph node metastases: two case reports.
    Takanami K; Kaneta T; Yamada T; Kinomura S; Yamada S; Fukuda H; Takahashi S
    Clin Nucl Med; 2008 Apr; 33(4):258-61. PubMed ID: 18356663
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dramatic change in 18F-FDG uptake in a sarcoidosis case showing spontaneous recovery.
    Ito K; Miyata Y; Minamimoto R; Kubota K
    Clin Nucl Med; 2014 Apr; 39(4):376-8. PubMed ID: 23640228
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Value of 18F-fluorodeoxyglucose-PET in the diagonosis and monitoring of pulmonary sarcoidosis: a case report].
    Kaneko M; Tomioka H; Kaneda T; Kubot M; Tani S; Fujii H; Katsuyama E; Okazaki M
    Nihon Kokyuki Gakkai Zasshi; 2008 Jun; 46(6):505-9. PubMed ID: 18593000
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Sarcoidosis-lymphoma syndrome].
    Partanen A; Pukkila S; Jantunen E
    Duodecim; 2016; 132(7):661-5. PubMed ID: 27188091
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Laryngeal sarcoidosis detected by FDG positron emission tomography.
    Kaira K; Ishizuka T; Yanagitani N; Sunaga N; Hisada T; Mori M
    Clin Nucl Med; 2008 Dec; 33(12):878-9. PubMed ID: 19033796
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of (18)F-fluorodeoxyglucose positron emission tomography (FDG PET) and cardiac magnetic resonance (CMR) in corticosteroid-naive patients with conduction system disease due to cardiac sarcoidosis.
    Ohira H; Birnie DH; Pena E; Bernick J; Mc Ardle B; Leung E; Wells GA; Yoshinaga K; Tsujino I; Sato T; Manabe O; Oyama-Manabe N; Nishimura M; Tamaki N; Dick A; Dennie C; Klein R; Renaud J; deKemp RA; Ruddy TD; Chow BJW; Davies R; Hessian R; Liu P; Beanlands RSB; Nery PB
    Eur J Nucl Med Mol Imaging; 2016 Feb; 43(2):259-269. PubMed ID: 26359191
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.